The Methionine Synthase Reductase (MTRR) A66G and Methionine Synthase (MTR) A2756G Polymorphisms Might be a Risk Factor for Colorectal Cancer in People Living near the Southern Coast of the Caspian Sea

Document Type : Original Research

Authors
F. Nemati 1
F. Malakpour 2
R. Abdullahpour 3
M. Rajabzadeh 4
M. Gholampour 5
1 Assistant Professor in Animal Physiology, Department of Biology, Faculty of Basic Science, Islamic Azad University, Qaemshahr Branch, Mazandaran, Iran (*Corresponding author)
2 M.Sc. student of Biology, Islamic Azad University, Qaemshahr Branch, Mazandaran, Iran
3 Assistant Professor in Animal Genetics and Breeding, Department of Animal Science, Islamic Azad University, Qaemshahr Branch, Mazandaran, Iran
4 M.Sc. student of Biology, Islamic Azad University, Qaemshahr Branch, Mazandaran, Iran.
5 Department of Electrical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Abstract
A case-control study was designed to investigate the association between the risk of colorectal cancer and genetic variation in four single-nucleotide polymorphism (SNPs) within genes involved in folate metabolism: C677T and A1298C of methylenetetrahydrofolate reductase (MTHFR), A66G of methionine synthase reductase (MTRR), and A2756G of methionine synthase (MTR). Genomic DNA was extracted from peripheral blood of 80 patients with newly diagnosed colorectal cancer and 100 non-cancer controls. The statistical analysis was done by logistic regression. The results showed that the MTR and MTRR SNPs were significantly associated with an increased risk of colorectal cancer (p<0.01). Moreover, no significant association was found between MTHFR C677T and MTHFR A1298C polymorphisms and the risk of colorectal cancer. These findings suggest that the MTRR A66G and MTR A2756G polymorphisms might be some genetic risks factor for colorectal cancer in the studied population.

Keywords

1. Macrae FA. Colorectal cancer: Epidemiology, risk factors, and protective factors. Uptodate com [ažurirano 9. lipnja 2017. 2016 Jan.
2. Pabalan, N., Singian, E., Tabangay, L., Jarjanazi, H. and Singh, N., 2015. Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis: Supplementary Issue: Biomarkers for Colon Cancer. Biomarkers in cancer, 7, pp.BIC-S25251.
3. Scotti M, Stella L, Shearer EJ, Stover PJ. Modeling cellular compartmentation in one‐carbon metabolism. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2013 May;5(3):343-65. doi: 10.1002/wsbm.1209.
4. Yadav, S., Longkumer, I., Joshi, S. and Saraswathy, K.N., 2021. Methylenetetrahydrofolate reductase gene polymorphism, global DNA methylation and blood pressure: a population based study from North India. BMC Medical Genomics, 14(1), pp.1-8.
5. Crider, K.S., Yang, T.P., Berry, R.J. and Bailey, L.B., 2012. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Advances in nutrition, 3(1), pp.21-38.
6. Barroso, M., Handy, D.E. and Castro, R., 2019. The link between hyperhomocysteinemia and hypomethylation: Implications for cardiovascular disease. Journal of Inborn Errors of Metabolism and Screening, 5.
7. Wan, L., Li, Y., Zhang, Z., Sun, Z., He, Y. and Li, R., 2018. Methylenetetrahydrofolate reductase and psychiatric diseases. Translational psychiatry, 8(1), pp.1-12.
8. Petrone, I., Bernardo, P.S., Dos Santos, E.C. and Abdelhay, E., 2021. MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review. Genes, 12(4), p.587.
9. Kim, J.W., Jeon, Y.J., Jang, M.J., Kim, J.O., Chong, S.Y., Ko, K.H., Hwang, S.G., Oh, D., Oh, J. and Kim, N.K., 2015. Association between folate metabolism-related polymorphisms and colorectal cancer risk. Molecular and clinical oncology, 3(3), pp.639-648.
10. Lyon, P., Strippoli, V., Fang, B. and Cimmino, L., 2020. B vitamins and one-carbon metabolism: implications in human health and disease. Nutrients, 12(9), p.2867.
11. Guraya, S.Y., 2014. Chemopreventive role of vitamin D in colorectal carcinoma. Journal of Microscopy and Ultrastructure, 2(1), pp.1-6.
12. Nolfo, F., Rametta, S., Marventano, S., Grosso, G., Mistretta, A., Drago, F., Gangi, S., Basile, F. and Biondi, A., 2013. Pharmacological and dietary prevention for colorectal cancer. BMC surgery, 13(2), pp.1-11.
13. Izmirli M. A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Molecular biology reports. 2013 Jan 1;40(1):625-37. doi: 10.1007/s11033-012-2101-2.
14. Team RC. R: A language and environment for statistical computing.
15. Warnes G, Gorjanc G, Leisch F, Man M. genetics: Population Genetics. R package version 1.3. 8.1. The Comprehensive R Archive Network. 2013.
16. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492.
17. Shadmani FK, Ayubi E, Khazaei S, et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiology and health. 2017;39. Doi: 104178/epih.e2017020
18. Ghorbani, M., Azghandi, M., Khayami, R., Baharara, J. and Kerachian, M.A., 2021. Association of MTHFR C677T variant genotype with serum folate and Vit B12 in Iranian patients with colorectal cancer or adenomatous polyps. BMC Medical Genomics, 14(1), pp.1-8.
19. Yari, A., Meybodi, S.M.E., Karam, Z.M., Samoudi, A., Hashemi, F., Aalipour, M., Abadi, M.F.S. and Dabiri, S., 2021. Association of MTHFR 677C> T and 1298A> C genetic polymorphisms with colorectal cancer: genotype and haplotype analysis in a Southeast Iranian population. Gene Reports, p.101399.
20. Panprathip, P., Petmitr, S., Tungtrongchitr, R., Kaewkungwal, J. and Kwanbunjan, K., 2019. Low folate status, and MTHFR 677C> T and MTR 2756A> G polymorphisms associated with colorectal cancer risk in Thais: a case-control study. Nutrition Research, 72, pp.80-91.
21. Wettergren, Y., Odin, E., Carlsson, G. and Gustavsson, B., 2010. MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. Molecular medicine, 16(9), pp.425-432.
22. Xu, L., Qin, Z., Wang, F., Si, S., Li, L., Lin, P., Han, X., Cai, X., Yang, H. and Gu, Y., 2017. Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis. Bioscience reports, 37(6).
23. Theodoratou E, Farrington SM, Tenesa A, et al. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiology and Prevention Biomarkers. 2008 Jan 1;17(1):171-82. doi: 10.1158/1055-9965.EPI-07-0621.
24. Zhou D, Mei Q, Luo H, Tang B, Yu P. The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer. International journal of biological sciences. 2012;8(6):819. doi: 10.7150/ijbs.4462.
25. Cui LH, Shin MH, Kim HN, et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC medical genetics. 2011 Dec 1;12(1):28. doi: 10.1186/1471-2350-12-28.
26. Pande, M., Chen, J., Amos, C.I., Lynch, P.M., Broaddus, R. and Frazier, M.L., 2007. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiology and Prevention Biomarkers, 16(9), pp.1753-1759.
27. Huang, Y., Han, S., Li, Y., Mao, Y. and Xie, Y., 2007. Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. Journal of human genetics, 52(1), pp.73-85.
28. Pardini B, Kumar R, Naccarati A, et al. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case–control study from the Czech Republic. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2011 Mar 18;721(1):74-80. doi: 10.1016/j.mrgentox.2010.12.008.
29. Fernández-Peralta AM, Daimiel L, Nejda N, et al. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy. International journal of colorectal disease. 2010 Feb 1;25(2):141-51. doi: 10.1007/s00384-009-0779-y.
30. Shiao, S.P.K., Lie, A. and Yu, C.H., 2018. Meta-analysis of homocysteine-related factors on the risk of colorectal cancer. Oncotarget, 9(39), p.25681.
31. Lee JE, Wei EK, Fuchs CS, et al. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case–control studies. Cancer, Causes Control, Pap. Symp. 2012 Apr 1;23(4):537-45. doi: 10.1007/s10552-012-9911-3.
32. Guerreiro CS, Carmona B, Gonçalves S, et al. Risk of colorectal cancer associated with the C677T polymorphism in 5, 10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. The American journal of clinical nutrition. 2008 Nov 1;88(5):1413-8. doi: 10.3945/ajcn.2008.25877.
33. Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015 May 1;148(6):1244-60. doi: 10.1053/j.gastro. 12.035.
34. Mokarram P, Naghibalhossaini F, Firoozi MS, et al. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J. Gastroenterol: WJG. 2008 Jun 21;14(23):3662. doi: 10.3748/wjg.14.3662.
35. Naghibalhossaini F, Mokarram P, Khalili I, et al. MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer genetics and cytogenetics. 2010 Mar 1;197(2):142-51. doi: 10.1016/j.cancergencyto.2009.11.014.
36. Kim DH. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2007 Sep 1;622(1-2):14-8. doi: 10.1016/j.mrfmmm.2007.04.012.
37. Lima CS, Nascimento H, Bonadia LC, et al. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. International journal of colorectal disease. 2007 Jul 1;22(7):757. doi: 10.1007/s00384-006-0237-z.
Pathobiology Reserach
Volume 24, Issue 2
February 2021
Pages 27-33